About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
America is a laboratory for ideas – a testing ground to advance human thought and potential from which entire industries have been born – from media and entertainment, to tech giants capitalizing on the great internet awakening, to scientific discoveries and life-saving cures.
Where
The Newseum, 7th Floor
555 Pennsylvania Avenue, NW
Washington, DC
When
Tuesday, July 17, 2018
7:45 AM - 10:00 AM
Speakers
- Andrei Iancu, under secretary of Commerce for Intellectual Property; director of the USPTO
- Margaret Anderson, managing director, Deloitte Consulting
- Robert Atkinson, president, Information Technology and Innovation Foundation
- Steve Clemons, Washington editor at large, The Atlantic
- Chip Davis, president and CEO, Association for Accessible Medicine
- Yvonne Greenstreet, chief operating office, Alnylam
- David Ricks, chairman and CEO, Eli Lilly and Company
- Roxanne Watson, organ donor advocate
- Abbie Celniker, partner, Third Rock Ventures
- Olga Khazan, staff writer, The Atlantic
- Kathleen Koch, author and journalist; founder, Leaderslink
Event
Research and Development
The State of Care: Innovation & Access
The State of Care: Innovation & Access image